Chad Terhune

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

Robert F. Kennedy Jr. faced questions from Congress about his own potential conflicts of interest during a confirmation hearing.

Dozens of scientists, researchers and other employees at the U.S. National Institutes of Health issued a rare public rebuke Monday criticizing the Trump administration for major spending cuts that “harm the health of Americans and people across the globe,” politicize research and “waste public resources.”

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows.

Dr. Ana Montanez is working overtime in Lubbock to contact vaccine-hesitant parents, explaining the grave risks posed by a disease that most American families have never seen, and one that can be prevented through immunization.

First there were the fast-moving, devastating fires. Now, amid the ruins of homes burned to the ground in the Los Angeles area blazes this month, workers are starting the massive, delicate task of removing hazardous debris as a prelude to rebuilding.

"Oh no. Hell no. That fire took everything out of me," said Karen Myles, 66. "I’m going to fly away somewhere, somewhere nice. Maybe Colorado."

As embers began raining down on Altadena last week, Jason Salit sent his wife and two college-age children away.

Thousands of jubilant fans packed Southern California's Rose Bowl on New Year's Day for a college football playoff game.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers and insurers, according to an analysis shared with Reuters.